Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine for Relapse Prevention in Recurrent Depressive Disorder: a Randomised, Controlled, Pilot Trial: the KINDRED Trial

NCT02661061 is registered in ClinicalTrials.gov with St Patrick's Hospital, Ireland as lead sponsor.

NCT NCT02661061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02661061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine for Relapse Prevention in Recurrent Depressive Disorder: a Randomised, Controlled, Pilot Trial: the KINDRED Trial
Lead sponsor
St Patrick's Hospital, Ireland
Phase
Phase 1
Overall status
Terminated
Start date
December 31, 2015
Completion date
May 23, 2018
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, major depressive disorder, recurrent depressive disorder, relapse